Press Releases Merck KGaA OTC Markets

Equities

MKKGY

US5893392093

Market Closed - OTC Markets Other stock markets 01:29:59 08/06/2024 am IST			5-day change	1st Jan Change
36.98 ^USD	-0.99%		+1.85%	+15.82%

07/06	Health Care Up as Defensive Rotation Continues - Health Care Roundup	DJ
06/06	Merck KGaA Completes EUR180 Million German Distribution Center Expansion	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Merck : Q1 24 Financial Statement	16/05	PU
Merck : Q1 24 Earnings Presentation	16/05	PU
Merck : Q1 24 Quarterly statement	15/05	PU
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development	05/04	AQ
Merck's Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment	04/04	AQ
Merck : Prospectus - C-029771	29/03	PU
DD: Merck KGaA: Dr. Matthias Heinzel, buy	27/03	EQ
DD: Merck KGaA: Peter Guenter, buy	27/03	EQ
Merck KGaA, Darmstadt, Germany, Invests More than EUR 300 Million in New Life Science Production Site in Korea	21/03	AQ
AFR: Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	25/01	EQ
AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	25/01	EQ
Biocytogen Launches RenBiologics, a Sub-Brand Focused on Out-Licensing Fully Human Antibodies for Therapeutic Development	24/01	AQ
Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid	05/01	AQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	13/12	EQ
Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide	06/12	EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27/11	EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	24/11	EQ
Veeva European Commercial Summit Gathers Life Sciences Industry Leading the Next Generation of Commercial Excellence	23/11	AQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	22/11	EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	21/11	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

MERCK : A lower starting point for future growth

May 27, 2024 at 01:06 pm IST

Merck KGaA : A European big pharma with positive momentum

January 20, 2023 at 04:21 pm IST